21
https://pubmed.ncbi.nlm.nih.gov/38112980
In a systematic review and meta-analysis, fidaxomicin was found to significantly improve achieving sustained clinical cure in patients with Clostridioides difficile infection, compared to vancomycin, although more studies are needed to compare fidaxomicin with other antibiotics.